When a drug causes an unintended effect, that is an adverse drug reaction (ADR); they can range from mild to severe or even ...
CROSS-SPECIES BBB-PENETRANT IV-DELIVERED AAV GENE THERAPY PROVIDES BROAD AND ROBUST CNS TAU LOWERING IN TAUOPATHY MOUSE AND NON-HUMAN PRIMATE. Wencheng Liu, Ph.D., ID:419.
Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...
Cannabis Growth Cannabis has been a booming industry in the USA and many other countries in the past decade. This followed a slow, but steady trend toward full legalization, even if doing so at the US ...
R&D Expenses: Research and development expenses for the year ended December 31, 2024 were $38.8 million, compared to $40.6 million for the year ended December 31, 2023. The decrease was primarily due ...
In a manuscript published in the American Journal of Psychiatry titled "Psychiatric Genetics in Clinical Practice: Essential ...
The FDA has approved the first therapy to address hyperphagia for children and adults aged 4 years and older with ...
Psychiatric disorders challenge us deeply. At the University of Arizona, researchers dissect their molecular roots, focusing ...
Japanese researchers used a nonviral piggyBac system to genetically modify cynomolgus monkeys, enabling more accurate disease ...
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
The U.S. Food and Drug Administration approved Soleno Therapeutics' drug to treat a rare genetic disorder on Wednesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback